Dose escalation should proceed according to FDA-approved titration schedules, typically every 4 weeks, though individual tolerance may necessitate slower progression
One small observational study of women with PCOS who continued metformin after semaglutide withdrawal found roughly one-third of the weight regained at two years rather than two-thirds, with most participants still below their starting weight
PlexusDx Guidance: Combining GLP-1 and Birth Control Safely PlexusDx recommends that patients using hormonal birth control discuss their contraceptive method during the initial consultation before starting semaglutide injection or other GLP-1 compounds
Many patients at Tyde Wellness have reported an average body weight loss of 15% after 68 weeks of participating in comprehensive support programs
I dont think weve ever seen anything like this
The product should not be used by children, pregnant women, or breastfeeding mothers